Kidney International Reports

Papers
(The H4-Index of Kidney International Reports is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
POS-652 THE DIRECT COST OF DIALYSIS IN SRI LANKA177
Imagining a Better Outcome for Chronic Antibody-Mediated Rejection—Will Blocking Interleukin-6 Signaling Help?150
Epigenome-Wide Association Studies of DNA Methylation in Kidney Diseases118
POS-253 THE RELATIONSHIP BETWEEN THE NEUTROPHILS / LYMPHOCYTES RATIO AND THE PLATELETS / LYMPHOCYTES RATIO WITH THE OCCURRENCE OF CARDIOVASCULAR COMPLICATIONS IN HEMODIALYSIS PATIENTS100
POS-260 Polycystic kidney disease in Chad: about 26 cases98
POS-336 SEMAGLUTIDE 2.4 MG AND 1.0 MG IMPROVED ALBUMINURIA IN ADULTS WITH OVERWEIGHT/OBESITY AND TYPE 2 DIABETES IN STEP 277
POS-466 THE CRITICAL ROLE OF A NEPHROLOGIST IN KIDNEY STONES: A TALE OF PRIMARY HYPEROXALURIA76
POS-206 Subphenotyping using combined biomarkers and clinical data reveals novel patterns within high-risk patients with diabetic kidney disease75
POS-187 PROGNOSTIC ROLES OF URINARY TUBULAR INJURY MARKERS IN DIABETIC NEPHROPATHY64
POS-074 Recurrent subcutaneous Phaeohyphomycosis with bone involvement after kidney transplant: A case report64
POS-084 OUTCOMES OF BIOPSY PROVEN BKV NEPHROPATHY POST KIDNEY TRANSPLANT – A SINGLE CENTRE EXPERIENCE58
WCN23-0377 THE ROLE OF INTRA-CATHETER TAUROLIDINE IN PREVENTING RELAPSING AND REPEAT PERITONEAL DIALYSIS-RELATED PERITONITIS57
WCN23-0894 APPLICATION OF KDQOL SF- V 1.3 IN OLDER PATIENTS WHO MADE PREVALENT HEMODIALYSIS52
WCN23-0120 MEDIUM AND LONG TERM ANTIBODY RESPONSE TO COVID-19 VACCINATION IN PATIENTS RECEIVING HEMODIALYSIS (HD) - A CROSS SECTIONAL STUDY49
POS-237 Prevalence and risk factors of anemia among non-dialysis chronic kidney disease patients: a single-centre, cross-sectional study from Malaysia48
POS-216 OUTCOME AMONG ELDERLY WITH ADVANCED KIDNEY DISEASE MANAGED NON-DIALYSIS VERSUS DIALYSIS. A SINGLE CENTRE EXPERIENCE46
WCN23-0355 A SEASON OF ACUTE KIDNEY INJURY POST BREAST AUGMENTATION46
POS-240 CGAS/STING DECREATES RENAL FIBROSIS AND INFLAMMATORY RESPONSE INDUCED BY HYPERTENSION BY REGULATING GLUTATHINE METABOLISN46
POS-605 THE RELEVANCE OF A GERIATRIC ASSESSMENT IN ELDERLY HEMODIALYSIS PATIENTS45
POS-328 SUPPRESSION OF ER-ASSOCIATED DEGRADATION BY INTRAGLOMERULAR CROSS-COMMUNICATION BETWEEN MESANGIAL CELLS AND PODOCYTES CAUSES PODOCYTE INJURY IN DIABETIC KIDNEY DISEASE44
POS-611 HEMODIALYSIS TUNNELED-CATHETER RELATED INFECTIONS: RETROSPECTIVE STUDY IN PUBLIC CENTER OF DAKAR44
POS-125 PERSISTENT MACROSCOPIC HAEMATURIA IN SYSTEMIC ERYTHEMATOSUS43
POS-321 A RARE NON DIABETIC GLOMERULAR DISEASE IN DIABETIC43
POS-402 UNCOUPLING PROTEIN 1 (UCP1) INHIBITS EPITHELIAL MESENCHYMAL TRANSFORMATION AND EXTRACELLULAR MATRIX AGGREGATION IN RENAL INTERSTITIAL FIBROSIS THROUGH SIRT3 DEPENDENT REACTIVE OXYGEN SPECIES (42
POS-123 Determinants of Outcome in Crescentic Glomerulonephritis: A Retrospective Study of 78 patients from Tunisia, North Africa42
POS-429 HYPERTENSION IN TUNISIAN ADULTS WITH POLYCYSTIC KIDNEY DISEASE : A RETROSPECTIVE COHORT OF 74 CASES42
WCN23-0525 A new therapeutic strategy in severe IgA nephropathy by MP pulse and SVF42
WCN23-0582 ECULIZUMAB FOR BEVACIZUMAB-INDUCED THROMBOTIC MICROANGIOPATHY41
POS-628 COMPARISON OF CITRATE ANTICOAGULATION STRAGEGIES IN HEMODIALYSIS PATIENTS AT HIGH RISK OF BLEEDING: A MUTICENTER PROSPECTIVE OBSERVATIONAL COHORT STUDY40
WCN23-0334 VITAMIN D LEVEL IN SLE PATIENTS WITH OR WITHOUT RENAL INVOLVEMENT AND IT’S RELATIONSHIP WITH DISEASE ACTIVITY (SLEDAI SCORE)40
POS-439 The PROPKD score affect renal involvement in patients with tolvaptan-treated autosomal dominant polycystic kidney disease ?40
WCN23-0427 COENZYME Q10 SUPPLEMENTATION IN AN ADULT PATIENT WITH COQ8 MUTATION AND NEPHROTIC SYNDROME ALLEVIATES RENAL FUNCTION DETERIORATION AND REMITS PROTEINURIA39
WCN23-1170 ASSOCIATION OF ANGIOTENSINOGEN GENE POLYMORPHISM WITH NEPHROPATHY IN TYPE 2 DIABETIC PATIENTS OF BANGLADESH37
WCN23-0726 UREA REDUCTION IN ACUTE KIDNEY INJURY AND MORTALITY RISK36
POS-133 CASE REPORT OF DISSEMINATED KLEBSIELLA INFECTION IN T2DM LEADING TO CKD36
POS-245 THROMBOMODULIN ACTIVATION DRIVEN BY LIVER X RECEPTOR AGONIST T0901317 ATTENUATES RENAL INFLAMMATION IN DIABETIC NEPHROPATHY36
0.12916994094849